who should not use semaglutide Take Wegovy? 🚫 Who Should NOT Take

With diagnosed diabetes affecting an estimated 3.9 million Canadians and Canada recognised as the world's second-largest market for semaglutide, immediate availability is expected to be a meaningful differentiator for patients, payers and the healthcare system

The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozempic), and liraglutide (aka Saxenda and Victoza).

The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial, potentially expanding the already wildly popular drugs use beyond diabetes and weight loss and offering a new treatment option where few are available.

Discover how combining HRT and GLP-1 therapy helps women in perimenopause and menopause achieve better weight loss, improved metabolic health, and long-term wellness